This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

reputable news agency

proofread

New treatment modality may reduce obesity in schizophrenia patients

obese
Credit: Pixabay/CC0 Public Domain

In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31 in Schizophrenia Bulletin.

Dongyu Kang, M.D., from The Second Xiangya Hospital of Central South University in Changsha, China, and colleagues conducted a double-blind, randomized trial to examine the efficacy of noninvasive magnetic stimulation techniques in reducing obesity among with schizophrenia. Forty with were recruited and randomly assigned to active intervention, which included 50 accelerated cTBS sessions over the left primary motor area, or sham intervention.

The researchers found that the active group had a significant decrease in body weight and body mass index after the intervention; this improvement persisted at the one-month follow-up. In the active group, the score on the Barratt Impulsivity Scale decreased and mediated the effect of accelerated cTBS on .

After the active intervention, the late positive potential component, which is related to motivated attention and emotional processing, decreased in frontal brain regions and increased in posterior regions in the food picture cue electroencephalograph task.

"The intervention was found to be associated with decreased impulsivity and increased motivated attention allocation to food-related cues," the authors write. "These findings are particularly noteworthy, considering the severe metabolic side effects associated with many second-generation antipsychotics."

More information: Dongyu Kang et al, The Effect of Accelerated Continuous Theta Burst Stimulation on Weight Loss in Overweight Individuals With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial, Schizophrenia Bulletin (2023). DOI: 10.1093/schbul/sbad144

Copyright © 2023 HealthDay. All rights reserved.

Citation: New treatment modality may reduce obesity in schizophrenia patients (2023, November 18) retrieved 24 February 2024 from https://medicalxpress.com/news/2023-11-treatment-modality-obesity-schizophrenia-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Brain imaging may predict motivation for behavior change in alcohol use disorder

10 shares

Feedback to editors